These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 2457657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
    Motzer RJ, Geller NL, Bosl GJ.
    Cancer; 1990 Sep 01; 66(5):857-61. PubMed ID: 1696846
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M, Simon SD, de Góes GM.
    AMB Rev Assoc Med Bras; 1985 Sep 01; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract] [Full Text] [Related]

  • 9. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
    Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC.
    J Clin Oncol; 1988 Jun 01; 6(6):1031-40. PubMed ID: 2453619
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP, Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    J Clin Oncol; 2008 Jan 20; 26(3):421-7. PubMed ID: 18202419
    [Abstract] [Full Text] [Related]

  • 12. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA, Bulanov AA, Titov DA, Sokolov AV, Sholokhov VN, Garin AM.
    Urol Nefrol (Mosk); 1996 Jan 20; (2):26-9. PubMed ID: 8677548
    [Abstract] [Full Text] [Related]

  • 13. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S, Théodore C, Bekradda M, Farhat F, Terrier-Lacombe MJ, Droz JP.
    Am J Clin Oncol; 1997 Apr 20; 20(2):184-8. PubMed ID: 9124197
    [Abstract] [Full Text] [Related]

  • 14. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
    Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ.
    N Engl J Med; 1987 Jun 04; 316(23):1435-40. PubMed ID: 2437455
    [Abstract] [Full Text] [Related]

  • 15. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, ten Bokkel Huinink WW, Rea LA, Collette L, Sylvester R.
    J Clin Oncol; 1997 May 04; 15(5):1837-43. PubMed ID: 9164193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
    Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P.
    J Clin Oncol; 1993 Apr 04; 11(4):598-606. PubMed ID: 8386751
    [Abstract] [Full Text] [Related]

  • 18. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K, Prow DM, Do KA, Wang X, Finn L, Kim J, Daliani D, Papandreou CN, Tu SM, Millikan RE, Pagliaro LC, Logothetis CJ, Amato RJ.
    Br J Cancer; 2002 May 20; 86(10):1555-60. PubMed ID: 12085204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.